Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
$80
1-199 Kilogram
$75
200-499 Kilogram
$70
≥500 Kilogram
Product Description
Urolithin B is a naturally occurring gut microbiota-derived metabolite associated with the metabolism of ellagitannins and ellagic acid found in certain plant foods. As a specialized research and nutritional ingredient, Urolithin B powder is used in ingredient development, analytical research, and formulation evaluation where identity, purity, and batch-to-batch consistency are important.
Urolithin B belongs to the urolithin family of compounds formed through microbial transformation of dietary polyphenols. It has attracted scientific interest for its biological activities and potential applications in nutritional ingredient research. Commercial Urolithin B powder is generally evaluated by chemical identity, assay purity, residual impurities, and suitability for the intended research or formulation use.
For B2B procurement, the key is to distinguish the identity and purity of the raw compound from the performance of a finished supplement or formulated product. Analytical documentation and clear intended-use specifications help buyers assess whether a material is appropriate for their project.
| Item | Specification |
|---|---|
| Product Name | Urolithin B |
| Other Name | 3-Hydroxybenzo[c]chromen-6-one |
| Product Category | Specialty polyphenol metabolite; research and nutritional ingredient |
| CAS Number | 1139-83-9 |
| Molecular Formula | C13H8O3 |
| Molecular Weight | 212.20 g/mol |
| Typical Appearance | White to off-white or pale-colored powder; appearance may vary with material grade and processing |
| Assay / Purity Grades | High-purity research grades are commonly offered at 98% or above; exact grade depends on the product specification |
| Identification | HPLC retention time and/or LC-MS comparison with a suitable reference standard |
| Assay Method | HPLC or UPLC; method conditions and calculation basis should be defined in the specification |
| Additional Quality Tests | May include water content, residual solvents, related substances, and elemental impurities according to intended use and applicable requirements |
| Solubility | Limited water solubility; compatibility should be evaluated in the intended solvent or formulation system |
| Particle Size | Standard or customized particle-size options can be discussed according to processing and formulation requirements |
| Storage | Keep tightly sealed in a cool, dry place, protected from light, moisture, and excessive heat |
| Shelf Life | A 24-month planning period is commonly used for stable, properly packaged specialty powders, subject to product-specific stability data and storage conditions |
| Packaging | Common options include 1 kg or 5 kg barrier foil bags and larger quantities in suitable fiber drums; customized packaging can be arranged |
| Documentation | Product specification and batch-specific COA are standard procurement documents; additional analytical or technical documents depend on the material and intended application |
| Applications | Analytical research, polyphenol-metabolite studies, ingredient development, and formulation feasibility evaluation |
Urolithin B is a distinct compound within the urolithin family, so buyers should not treat it as interchangeable with Urolithin A or a generic ellagic acid extract. The most useful procurement checks focus on chemical identity, assay interpretation, and the suitability of the material for its intended use.
A high assay percentage alone does not establish that a material is Urolithin B. Review the product identity and the analytical method used. HPLC or UPLC can support purity assessment, while LC-MS or comparison with an appropriate reference standard can provide additional identity evidence. For critical applications, request a batch-specific COA and review the underlying method and acceptance criteria.
Purity values may be reported on different bases, such as as-is material or a corrected basis. Water, residual solvents, and related substances can affect interpretation. Before comparing quotations, confirm that suppliers use comparable analytical methods, reporting bases, and impurity criteria rather than comparing percentages alone.
Urolithin B has limited water solubility. If the planned product is an aqueous liquid, beverage, or other water-rich system, evaluate solubility and physical stability before selecting a dosage form. A powder that meets a purity target may still require a suitable carrier, dispersion strategy, or alternative delivery approach for a specific formulation.
Material intended for analytical research may have different documentation and suitability requirements from an ingredient intended for a consumer product. For commercial food or supplement development, independently assess the applicable jurisdiction, ingredient status, permitted use, labeling requirements, and supporting safety documentation. A stated assay grade does not by itself establish regulatory authorization or finished-product suitability.
Reliable procurement begins with a clear specification and a batch-specific certificate of analysis. Buyers should review the identity test, assay method, acceptance limits, and any additional quality attributes relevant to the application. Where required, additional testing may address residual solvents, elemental impurities, water content, microbiological quality, or other risk-based parameters.
For method-sensitive projects, analytical comparability matters as much as the headline purity. Confirm the test method, reference standard, sample preparation, and calculation basis before approving a material for routine use. Any regulatory or quality-system requirements should be assessed against the target market and intended application rather than assumed from the compound name alone.
Urolithin B powder is commonly packed in sealed barrier packaging for protection against moisture and environmental exposure. Typical commercial formats include small foil bags for laboratory or pilot-scale work and larger lined containers for bulk procurement. Packaging size, particle-size options, and order quantities can be tailored to the project.
Store the material tightly sealed in a cool, dry location and protect it from light and excessive heat. Keep the original label and batch documentation with the container. For long-term use, follow the supplier’s product-specific storage instructions and stability data.
For qualified projects, development discussions may cover bulk powder supply, packaging formats, labeling, and coordination of technical documentation. The feasibility of capsule, tablet, powder-blend, or other finished formats depends on the target market, ingredient suitability, formulation performance, and applicable regulatory requirements.
Before moving from ingredient evaluation to a commercial product, establish the target market, intended use, serving format, specification limits, packaging needs, and required supporting documentation. Private-label or contract-manufacturing arrangements should be evaluated against the project’s actual technical and regulatory requirements.
Urolithin B and Urolithin A are distinct compounds in the urolithin family, with different chemical structures and molecular formulas. They should be specified, tested, and purchased as separate ingredients. Research findings for one compound should not automatically be applied to the other.
HPLC or UPLC is commonly used for chromatographic purity assessment. Identity may be supported by retention-time comparison and, where appropriate, LC-MS or comparison with a suitable reference standard. The selected method should be appropriate for the material and clearly defined in the product specification.
Urolithin B has limited water solubility. Formulators should test compatibility in the intended solvent and finished-product matrix, including dispersion behavior and physical stability. Solubility performance in a particular formula should be established experimentally rather than inferred from the raw powder’s assay or appearance.
Start with the current product specification and a batch-specific COA containing identity, assay, and applicable impurity results. Depending on the intended use, buyers may also need method details, safety information, residual-solvent or elemental-impurity data, stability information, and documentation relevant to the destination market.
Urolithin B powder is a specialized polyphenol metabolite for analytical research and ingredient-development projects that require clear compound identity and defined purity criteria. Effective sourcing depends on verifying the analytical basis, matching the grade to the intended application, and evaluating solubility and regulatory suitability before formulation or commercialization.
Contact us today to request samples, a COA, technical documents, and a wholesale quotation.

Packaging & Delivery
| Selling Units: | Kilogram |
|---|
The file is encrypted. Please fill in the following information to continue accessing it